Key Developments: E I du Pont de Nemours and Co (DD)

DD on New York Consolidated

55.96USD
28 Jul 2015
Change (% chg)

$-0.77 (-1.36%)
Prev Close
$56.73
Open
$53.38
Day's High
$57.25
Day's Low
$52.79
Volume
11,883,587
Avg. Vol
5,831,715
52-wk High
$76.61
52-wk Low
$52.79

Search Stocks

Latest Key Developments (Source: Significant Developments)

E I du Pont de Nemours and Co declares dividend
6:00am EDT 

E I du Pont de Nemours and Co:Approved Q3 dividend of 38 cents per share, 444thconsecutive quarterly dividend since the company's first dividend in the fourth quarter of 1904.Says Q3 dividend of 38 cents per share of common stock is payable on Sept. 11 to stockholders of record at close of business on Aug. 14.Regular quarterly dividends of $1.125 per share on $4.50 series preferred stock and $0.875 cents per share on $3.50 series preferred stock also were declared, both payable on Oct. 23 to stockholders of record as of Oct. 9.  Full Article

E I du Pont de Nemours and Co gives FY 2015 EPS guidance
6:00am EDT 

E I du Pont de Nemours and Co:Says that it expects FY 2015 operating earnings to be about $3.10 per share, excluding $0.80 per share in previously anticipated full year earnings from Performance Chemicals.Says estimated negative currency impact expected to be about $0.60 per share.  Full Article

E I du Pont de Nemours and Co completes spin-off of The Chemours Co
Wednesday, 1 Jul 2015 06:00am EDT 

E I du Pont de Nemours and Co:Completed the separation of its Performance Chemicals segment through the spin-off of The Chemours Co.Chemours begins trading on July 1 on the New York Stock Exchange (NYSE) under the symbol CC.DuPont common stockholders receive one share of common stock of Chemours for every five shares of DuPont common stock they held on June 23.DuPont common stockholders will receive cash in lieu of fractional shares of Chemours.  Full Article

E I du Pont de Nemours's dupont pioneer gains exclusive license for genome-editing technology
Tuesday, 23 Jun 2015 08:02am EDT 

E I du Pont de Nemours and Co:Says Dupont Pioneer gains exclusive license for genome-editing technology from Vilnius university.Says financial details of the agreement were not disclosed.Says Vilnius university and Dupont have entered into a multi-year research collaboration to advance the development of the technology.  Full Article

E I du Pont de Nemours and Co and Kolon settle trade secret litigation
Thursday, 30 Apr 2015 01:21pm EDT 

Enters into a settlement agreement with Kolon Industries that resolves all outstanding litigation between the two companies:DuPont had filed a civil lawsuit against Kolon in 2009 for misappropriation of trade secrets and confidential information regarding DuPont(tm) Kevlar technology.Financial terms of the settlement include up-front and ongoing payments to DuPont.Further terms and conditions of settlement are confidential.Separately, Kolon also announced that it has entered into a Plea Agreement with the U.S. Department of Justice resolving all charges against Kolon arising from the United States Government investigation of conversion of trade secrets by certain Kolon entities and employees.Kolon pled guilty to a single count of Conspiracy to Convert Trade Secrets related to its para-aramid fiber products.Under the Plea Agreement and Restitution Order, Kolon is ordered to pay restitution to DuPont totaling $275 mln.  Full Article

E I du Pont de Nemours and Co Acquires Taxon Biosciences, Inc.
Wednesday, 22 Apr 2015 12:08pm EDT 

E I du Pont de Nemours and Co:Says it has agreed to acquire Taxon Biosciences, Inc., a microbiome discovery company.The financial terms of the agreement were not disclosed.Closing of the acquisition is expected in the second quarter.  Full Article

E I du Pont de Nemours and Co declares second quarter dividend
Tuesday, 21 Apr 2015 06:00am EDT 

E I du Pont de Nemours and Co:Declares a second quarter common stock dividend of 49 cents per share.Payable on June 12 to stockholders of record May 15.  Full Article

E I du Pont de Nemours and Co reaffirms FY 2015 outlook
Tuesday, 21 Apr 2015 06:00am EDT 

E I du Pont de Nemours and Co:Continues to expect to be at the low end of its previously communicated outlook range of $4.00-$4.20 operating earnings per share for FY 2015.It is including the full year outlook for the performance chemicals segment.FY 2015 EPS of $4.46 - Thomson Reuters I/B/E/S.  Full Article

E I du Pont de Nemours and Co declares first quarter dividend
Thursday, 29 Jan 2015 02:23pm EST 

E I du Pont de Nemours and Co:Declares a first quarter common stock dividend of 47 cents per share payable March 13, to stockholders of record Feb. 13.  Full Article

E. I. du Pont de Nemours and Co gives FY 2015 EPS outlook below analyst's estimates
Tuesday, 27 Jan 2015 06:00am EST 

E. I. du Pont de Nemours and Co:Expects FY 2015 operating earnings of $4.00 to $4.20 per share, including the full-year outlook for the Performance Chemicals segment.FY 2015 EPS of $4.46 - Thomson Reuters I/B/E/S.  Full Article

Photo

DuPont sees 'challenging' months ahead as farm sales weaken

- Chemical and crop company DuPont said the remainder of the year would be "challenging", as a strong dollar and persistently weak demand for its farm products continue to chip away at sales.

Search Stocks